Interferon beta 1b (IFN-β1b)

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication bias???
All congenital malformations (majors, minors, majors and minors, or unspecified)1.71 [0.37, 7.96]0%2 studies5,00121not evaluable
Major congenital malformations1.88 [0.33, 10.69]0%2 studies4,99821not evaluable

Growth parameters and prematurity
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication bias???
Preterm (< 37 weeks)1.32 [0.31, 5.56]61%3 studies20668not evaluable

Maternal consequences
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication bias???
Preeclampsia--0 study
1 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication bias???
2 non statistically significant endpoints reported in only one study

Long term consequences
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication bias???
1 non statistically significant endpoints reported in only one study

Intrauterine deaths
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication bias???
Intrauterine deaths (as a whole)1.70 [0.43, 6.67]57%2 studies6470not evaluable
1 non statistically significant endpoints reported in only one study